Wan Zhao-Kui, Follows Bruce, Kirincich Steve, Wilson Douglas, Binnun Eva, Xu Weixin, Joseph-McCarthy Diane, Wu Junjun, Smith Michael, Zhang Yan-Ling, Tam May, Erbe David, Tam Steve, Saiah Eddine, Lee Jinbo
Chemical and Screening Sciences, Wyeth Research, 200 Cambridge Park Drive, Cambridge, MA 02140, USA.
Bioorg Med Chem Lett. 2007 May 15;17(10):2913-20. doi: 10.1016/j.bmcl.2007.02.043. Epub 2007 Feb 20.
The following account describes our systematic effort to replace one of the carboxylate groups of our diacid thiophene PTP1B inhibitors. Active hits were validated using enzymatic assays before pursuing efforts to improve the potency. Only when the C2 carboxylic acid was replaced with another ionizable functional group was reversible and competitive inhibition retained. Use of a tetrazole ring or 1,2,5-thiadiazolidine-3-one-1,1-dioxide as a carboxylate mimetic led to the discovery of two unique starting series that showed improved permeability (PAMPA) and potency of the order of 300nM. The SAR from these efforts underscores some of the major challenges in developing small molecule inhibitors for PTP1B.
以下内容描述了我们为替换二酸噻吩PTP1B抑制剂的一个羧酸根基团而进行的系统性工作。在努力提高活性之前,通过酶促测定对活性命中物进行了验证。只有当C2羧酸被另一个可电离的官能团取代时,才保留了可逆性和竞争性抑制作用。使用四唑环或1,2,5-噻二唑烷-3-酮-1,1-二氧化物作为羧酸模拟物,导致发现了两个独特的起始系列,它们显示出改善的渗透性(PAMPA),活性约为300nM。这些工作所得出的构效关系凸显了开发PTP1B小分子抑制剂的一些主要挑战。